Hostname: page-component-cb9f654ff-r5d9c Total loading time: 0 Render date: 2025-07-31T19:24:05.720Z Has data issue: false hasContentIssue false
  • English
  • Français

A Study of Facial Dyskinesia in a Mental Hospital Population

Published online by Cambridge University Press:  29 January 2018

Sydney Brandon ,
Hamish Anderson McClelland  and
Colin Protheroe
Sydney Brandon
Affiliation:
University of Newcastle; University of Manchester The Royal Infirmary, Swinton Grove, Manchester M13 0EU
Hamish Anderson McClelland
Affiliation:
St. Nicholas Hospital, Gosforth, Newcastle upon Tyne, 3
Colin Protheroe
Affiliation:
St. Nicholas Hospital, Gosforth, Newcastle upon Tyne, 3
Get access Rights & Permissions [Opens in a new window]

Extract

Abnormal movements are common and accepted complications of phenothiazine therapy. They are usually regarded as of extrapyramidal origin, develop soon after medication is started and are often abolished by stopping the drug or giving specific chemotherapy. The commonly occurring syndromes are:

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 118 , Issue 543 , February 1971 , pp. 171 - 184
Copyright
Copyright © The Royal College of Psychiatrists, 1971 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ashcroft, G. W., Eccleston, D., and Waddell, J. L. (1965). ‘Recognition of amphetamine addicts.’ Brit. med. J., i, 57.Google Scholar
Bradley, P. B. (1963). ‘Phenothiazine derivatives.’ In Physiological Pharmacology, Vol. 1 (eds. Root, and Hofman, ). New York and London.Google Scholar
Crane, G. E. (1968). ‘Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.’ Amer. J. Psychiat., 124, Suppl. No. 8, 40–8.Google Scholar
Demars, J. C. A. (1966). ‘Neuromuscular effects of long term phenothiazine medication, electro-convulsive therapy and leucotomy.’ J. nerv. merit. Dis., 143, 73–9.Google Scholar
Edwards, H. (1970). ‘The significance of brain damage in persistent oral dyskinesia.’ Brit. J. Psychiat., 116, 271–5.CrossRefGoogle ScholarPubMed
Evans, J. H. (1965). ‘Persistent oral dyskinesia in treatment with phenothiazine derivatives.’ Lancet, i, 458–60.Google Scholar
Faurbye, A., Rasch, P. J., Petersen, P. B., Brandborg, G., and Pakkenberg, H. (1964). ‘Neurological symptoms in pharmacotherapy of psychoses.’ Acta psychiat. Scand., 40, 10–27.Google Scholar
Hunter, R., Earl, C. J., and Janz, D. (1964). ‘A syndrome of abnormal movements and dementia in leucotomized patients treated with phenothiazine medication.’ J. Neurol. Neurosurg. Psychiat., 27, 219–23.Google Scholar
Hunter, R., Earl, C. J., and Thornicroft, S. (1964). ‘An apparently irreversible syndrome of abnormal movements.’ Proc. Roy. Soc. Med., 57, 758–62.Google Scholar
Kline, N. S. (1968). ‘On the rarity of “irreversible” oral dyskinesias following phenothiazines.’ Amer. J. Psychiat., 124, Suppl. No. 8, 48–54.Google Scholar
Myrianthopoulos, N. C., Kurland, A. A., and Kurland, L. T. (1962). ‘Hereditary predisposition in drug-induced parkinsonism.’ Arch. Neurol. Chicago, 6, 5–9.CrossRefGoogle ScholarPubMed
Pryce, I. J., and Edwards, H. (1966). ‘Persistent oral dyskinesia in female mental hospital patients.’ Brit. J. Psychiat., 112, 983–7.CrossRefGoogle ScholarPubMed
Schonecker, M. (1957). ‘Ein eigentümliches Syndrom in oralen Bereich bei Megaphen Applikation.’ Nervenarzt, 28, 35.Google Scholar
Sigwald, J., Bouttier, D., and Courvoisier, S. (1959). ‘Les accidents neurologiques des médications neurologiques.’ Rev. Neurol., 100, 553–95.Google Scholar
Turunen, S., and Achte, K. A. (1967). ‘The buccolinguo-masticatory syndrome as a side effect of neuroleptics therapy.’ Psychiatric Quarterly, 41, 168–79.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.